Dr Balendu Prakash conduct a four-month long research at GSVM College, Kanpur, Uttar Pradesh in this subject and arrived at a conclusion that the present research is far better when compared to Livosetrigin and Monteculast research. The present research conducted by Dr Balendu Prakash is far more effective in curing the Nose Allergy (Allergic Rinutus), according to the study.

Providing this significant information to the media here on Thursday, Dr Balendu Prakash said about 20 percent to 30 percent of the population in India are suffering from Nose Allergy (Allergic Rinutus), and the same is increasing upto 60 percent in South and India. “This particular health problem is costing about Rs 340 crores ever year,” Dr Balendu Prakash added.

Providing the details of the research, Dr Balendu Prakash said about 18 herbal roots and mandur powder are used in the new medicine along with certain minerals that has resulted in becoming this medical formula. Our study revealed that this new medicine gives quick as well as sustained relief.

“After successful clinical trial as well as field trial, we have obtained permission for marketing this medicine. We have subjected this new medicine for third phase of clinical trial under the overall guidance of Dr Yashwanth K Rao, Chief of the Childen Department of GSVM Medical College, Kanpur,” Dr Balendu Prakash explained.

Dr Vrinda Nandi, a eminent scientist who has a long experience of three decades in the field of development of medicine, who is also a Doctorate in Chemistry, said, “I vouch for the complete and sustained relief as well as cure to the problem of Nose Allergy (Allergic Rinitus) through this newly researched medicine. I have knowledge and experience of about three decades. About a decade ago, I suffered from Allergic Rinitus due to two grave incidents. There was a problem in Gall Bladder. I suffered for three years. I took medicine from Dr Balendu Prakash at Dehdrdun, Uttarakhand. My problem was solved.

Clinical trial:

A total number of 250 allergy-related problems were divided into two groups. One group was provided with Ayurveda Formula (IIMBO) and another group was given Levosentryzine and Mentalucast for a period of 28 days. A factual report about the characteristic feature marks before administering the medicine of both the groups and after administering the medicine (TNSS) were taken. The immunity strength of the medicine (EGE) level was calculated. The outcome of the report was that both the medicinal groups have capability to reduce TNSS as well as GEG. However, it was found out that those who took IIMBO the problem was significantly reduced and cure.

“Thus the Ayurvedic cure is more significant and profound when compared to MR, according to the study,” Dr Vrinda Nandi explained.

This new research has been published in International Medical Journal “Curious” in its latest edition. This new research will also act as counter protection moderator to Ayurvedic medicine and will help mitigate the problem at the global level.

Dr Balendu Prakash, who was the personal physician of Dr K. R. Narayanan, former President of India, has come out with 37 research papers pertaining to the effectiveness of Ayurveda Medicine.

For more details, please contact Rishi U. Acharya – 79833 92736